A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels
PHASE3CompletedINTERVENTIONAL
Enrollment
305
Participants
Timeline
Start Date
January 31, 1997
Study Completion Date
December 31, 1997
Conditions
Heart Failure, CongestiveHeart Decompensation
Interventions
DRUG
nesiritide
All Listed Sponsors
lead
Scios, Inc.
INDUSTRY
NCT00271557 - A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels | Biotech Hunter | Biotech Hunter